Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

XBIT Relative to the S&P 500

XBIT Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the XBiotech Inc. (NASD:XBIT) seasonal charts above shows that a Buy Date of December 5 and a Sell Date of April 15 has resulted in a geometric average return of 15.5% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 39.25% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

To download XBIT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: XBIT